Production (Stage)
ArriVent BioPharma, Inc.
AVBP
$20.40
-$0.23-1.12%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -44.52% | 45.53% | 70.03% | 63.36% | 94.28% |
| Total Receivables | -42.29% | -34.30% | -54.09% | 190.70% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -15.75% | 10.60% | 298.95% | 186.21% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 2.84% | -14.69% | -35.47% | -48.13% | -- |
| Total Current Assets | -43.27% | 41.89% | 62.46% | 55.28% | -- |
|
|
|||||
| Total Current Assets | -43.27% | 41.89% | 62.46% | 55.28% | -- |
| Net Property, Plant & Equipment | -52.00% | -47.08% | 325.00% | 188.16% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 62.96% | -95.56% | -93.58% | 52.44% | -- |
| Total Assets | -34.27% | 68.57% | 60.84% | 55.33% | -- |
|
|
|||||
| Total Accounts Payable | 6.49% | -16.55% | -3.57% | -40.97% | -- |
| Total Accrued Expenses | 47.44% | 91.74% | 97.77% | 29.54% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -6.12% | 15.71% | 256.82% | 100.00% | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 29.83% | 48.61% | 50.12% | -5.58% | -- |
|
|
|||||
| Total Current Liabilities | 29.83% | 48.61% | 50.12% | -5.58% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -92.09% | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 28.06% | 46.50% | 50.67% | -4.82% | -- |
|
|
|||||
| Common Stock & APIC | 2.49% | 10,566.34% | 11,820.87% | 12,922.02% | -- |
| Retained Earnings | -72.72% | -50.99% | -59.31% | -61.26% | -- |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -36.25% | 268.19% | 309.26% | 350.43% | 473.31% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -36.25% | 268.19% | 309.26% | 350.43% | 473.31% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -36.25% | 70.30% | 61.44% | 59.47% | 82.12% |
|
|
|||||